Achmea Investment Management B.V. Lowers Stock Holdings in Mettler-Toledo International, Inc. (NYSE:MTD)

Achmea Investment Management B.V. decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 6.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,218 shares of the medical instruments supplier's stock after selling 2,153 shares during the period. Achmea Investment Management B.V. owned about 0.15% of Mettler-Toledo International worth $36,866,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of MTD. Farther Finance Advisors LLC boosted its holdings in Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock worth $78,000 after acquiring an additional 8 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its position in shares of Mettler-Toledo International by 3.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock valued at $374,000 after purchasing an additional 9 shares in the last quarter. Atlantic Union Bankshares Corp boosted its holdings in Mettler-Toledo International by 0.5% during the fourth quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier's stock worth $2,549,000 after purchasing an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares during the last quarter. Finally, Congress Asset Management Co. grew its position in Mettler-Toledo International by 1.8% in the 1st quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock worth $788,000 after purchasing an additional 12 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director now owns 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.77% of the company's stock.

Wall Street Analyst Weigh In

MTD has been the topic of several recent analyst reports. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Wells Fargo & Company lifted their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective on the stock in a research report on Monday, April 7th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their target price for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Finally, Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $1,300.36.

Mettler-Toledo International Stock Down 0.8%

MTD traded down $8.98 on Monday, hitting $1,175.56. The company's stock had a trading volume of 119,195 shares, compared to its average volume of 179,373. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,546.93. The firm has a market cap of $24.43 billion, a P/E ratio of 29.32, a price-to-earnings-growth ratio of 3.64 and a beta of 1.38. The company's 50 day simple moving average is $1,133.98 and its 200-day simple moving average is $1,197.21.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The business had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter last year, the company earned $8.89 EPS. The firm's revenue was down 4.6% compared to the same quarter last year. Equities analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.